Senate Democrats are set to introduce legislation requiring US Health Secretary RFK Jr. to disclose terms of the Trump administration's confidential "most favoured nation" drug pricing deals with 16 pharma companies, according to Axios
Importance
Level 1
- The bill stands little chance of advancing, Axios says, but challenges administration transparency
- Democrats argue that the deals offer minimal patient savings, and largely exclude Medicare and private insurance recipients